시장보고서
상품코드
1964478

주사용 의약품 첨가제 시장 규모, 점유율, 성장 분석 : 제품 유형별, 제제 유형별, 용도별, 최종 이용 산업별, 지역별 - 업계 예측(2026-2033년)

Pharmaceutical Excipients for injection Market Size, Share, and Growth Analysis, By Product Type (Solvents, Tonicity Agents), By Formulation Type, By Application, By End User Industry, By Region - Industry Forecast 2026-2033

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 주사용 의약품 첨가제 시장 규모는 2024년에 113억 달러로 평가되었으며, 2025년 121억 2,000만 달러에서 2033년까지 213억 달러로 성장할 전망입니다. 예측 기간(2026-2033년) 동안 CAGR은 7.3%로 예측됩니다.

세계 주사제 첨가제 시장은 완충제, 계면활성제, 지질 캐리어와 같은 필수 불활성 성분에 초점을 맞추고 있으며, 이는 저분자 주사제, 단클론항체, 백신과 같은 주사제 요법의 기능에 필수적입니다. 고순도 및 다기능 성분에 대한 수요는 주로 복잡한 비경구 생물학적 제제의 증가와 안정성 및 전달 시스템을 개선하기 위한 특수 첨가제의 필요성에 의해 주도되고 있습니다. AI와 자동화 실험의 활용을 포함한 최근 동향은 첨가제 조합 선택과 최적화를 향상시키고, 제제 공정을 크게 개선했습니다. 이러한 혁신은 효율성을 높이고 재료 낭비를 줄일 뿐만 아니라, 중소 공급업체들이 첨단 첨가제 솔루션을 도입하여 수익 기회를 확대하고 진화하는 시장 환경에서 경쟁력을 강화할 수 있도록 돕습니다.

주사제 첨가제 세계 시장 촉진요인

비경구 요법의 증가에 따라 용해도, 안정성, 생체적합성을 보장하는 첨가제에 대한 수요가 증가하여 주사제 제제의 수요를 견인하고 있습니다. 그 결과, 제조업체들은 약물의 무결성을 유지하고 면역원성을 최소화하며 무균 처리를 용이하게 하는 특수 첨가제 개발에 주력하고 있습니다. 이러한 변화는 맞춤형 첨가제 포트폴리오에 대한 투자를 촉진하고, 공급망 전반의 협업을 촉진하고 있습니다. 그 결과, 조달 및 적격성 평가 프로세스에 대한 중요성이 높아지고 기능성 첨가제를 위한 혁신이 급증하고 있습니다. 제제 개발자들은 주사제 제품에 대한 엄격한 안전 및 성능 기준을 충족하는 신뢰할 수 있는 성분을 적극적으로 찾고 있으며, 이는 시장의 성장을 촉진하고 있습니다.

세계 주사제 첨가제 시장의 억제요인

세계 주사제 첨가제 시장은 엄격하고 변화무쌍한 규제 요건으로 인해 심각한 제약에 직면해 있습니다. 이러한 규제는 공급업체와 제제 개발자에게 큰 부담을 주며, 안전성, 적합성, 제조 공정에 대한 철저한 문서화를 요구합니다. 이로 인해 개발 기간이 길어지고, 컴플라이언스 비용이 증가할 수 있습니다. 또한, 지역별 기준의 차이와 엄격한 불순물 관리로 인해 철저한 적격성 평가와 안정성 시험이 필요하며, 이는 중소 제조업체에게 도전이 되어 신규 첨가제 도입에 걸림돌이 되고 있습니다. 그 결과, 제조업체는 기존 재료를 우선시하는 보수적인 조달 전략을 채택하는 경향이 있어 혁신적인 첨가제의 신속한 채택을 저해하고 시장의 다양화와 성장을 제한하고 있습니다.

주사제 첨가제 세계 시장 동향

세계 주사제 첨가제 시장에서는 생체기능성 첨가제의 혁신이 두드러지게 나타나고 있습니다. 개발자들은 복잡한 주사제 치료제의 안정성, 용해도, 전달성을 향상시키는 새로운 첨가제 화학 및 다기능 소재에 집중하고 있습니다. 이러한 추세는 생체분자의 무결성을 보호하고, 조절 방출 메커니즘을 가능하게 하며, 면역원성 반응을 감소시키는 첨가제의 중요성을 강조하고 있습니다. 그 결과, 첨가제 제조업체와 생물학적 제제 개발자 간의 협력이 급증하고 있으며, 차세대 치료법에서 제제 설계의 유연성을 촉진하고 있습니다. 다양한 치료 프로파일과 변화하는 임상적 요구에 대응하기 위해 모듈식, 용도별 첨가제 플랫폼이 등장하여 개발 프로세스를 크게 효율화하고 있습니다.

자주 묻는 질문

  • 세계 주사용 의약품 첨가제 시장 규모는 어떻게 되며, 향후 성장 전망은 어떤가요?
  • 주사제 첨가제 시장의 주요 촉진 요인은 무엇인가요?
  • 주사제 첨가제 시장의 주요 억제 요인은 무엇인가요?
  • 주사제 첨가제 시장에서 최근의 주요 동향은 무엇인가요?
  • 주사제 첨가제 시장에서 주요 기업은 어디인가요?

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

세계의 주사용 의약품 첨가제 시장 규모 : 제품 유형별 & CAGR(2026-2033년)

세계의 주사용 의약품 첨가제 시장 규모 : 제제 유형별 & CAGR(2026-2033년)

세계의 주사용 의약품 첨가제 시장 규모 : 용도별 & CAGR(2026-2033년)

세계의 주사용 의약품 첨가제 시장 규모 : 최종 이용 산업별 & CAGR(2026-2033년)

세계의 주사용 의약품 첨가제 시장 규모 & CAGR(2026-2033년)

경쟁 정보

주요 기업 개요

결론과 제안

KSM 26.03.23

Global Pharmaceutical Excipients For Injection Market size was valued at USD 11.3 Billion in 2024 and is poised to grow from USD 12.12 Billion in 2025 to USD 21.3 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global pharmaceutical excipients for injection market focuses on essential inactive ingredients like buffers, surfactants, and lipid carriers, which are vital for the functionality of injectable therapies such as small-molecule injectables, monoclonal antibodies, and vaccines. The demand for high-purity, multifunctional ingredients is driven primarily by the rise in complex parenteral biologics and the need for specialized excipients that enhance stability and delivery systems. Recent developments, including the utilization of AI and automated experimentation, have significantly improved formulation processes by enabling better selection and optimization of excipient combinations. These innovations not only increase efficiency and reduce material waste but also empower smaller suppliers to introduce advanced excipient solutions, broadening revenue opportunities and enhancing competitiveness in the evolving market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients For Injection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients For Injection Market Segments Analysis

Global pharmaceutical excipients for injection market is segmented by product type, formulation type, application, end user industry and region. Based on product type, the market is segmented into Solvents, Tonicity Agents, Buffer Agents, Surfactants, Preservatives, Antioxidants, Chelating Agents, Viscosity Enhancers, Colorants, Stabilizers and Others. Based on formulation type, the market is segmented into Water-Based Injection, Oil-Based Injection, Aqueous Solution and Non-Aqueous Solution. Based on application, the market is segmented into Lyophilized Injections, Non-Lyophilized Injections, Emulsion Injections and Suspension Injections. Based on end user industry, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Laboratories, Hospitals & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Excipients For Injection Market

The rise in parenteral therapies has led to an increased need for excipients that guarantee solubility, stability, and biocompatibility, thereby driving the demand for injectable formulations. As a result, manufacturers are focusing on developing specialized excipients that preserve drug integrity, minimize immunogenicity, and facilitate sterile processing. This shift prompts investments in customized excipient portfolios and fosters collaboration throughout supply chains. Consequently, there is a heightened emphasis on procurement and qualification processes, along with a surge in innovation aimed at functional excipients. Formulators are actively in search of reliable components that comply with rigorous safety and performance standards for injection products, further propelling market growth.

Restraints in the Global Pharmaceutical Excipients For Injection Market

The Global Pharmaceutical Excipients for Injection market faces significant constraints due to stringent and dynamic regulatory requirements. These regulations impose a heavy burden on suppliers and formulators, necessitating exhaustive documentation regarding safety, compatibility, and manufacturing processes, which can extend development timelines and escalate compliance costs. Additionally, varying regional standards and strict impurity controls require thorough qualification and stability testing, posing challenges for smaller manufacturers and hindering the introduction of new excipients. As a result, manufacturers tend to adopt a conservative procurement strategy that prioritizes established materials, thus impeding the swift adoption of innovative excipients and restricting overall market diversification and growth.

Market Trends of the Global Pharmaceutical Excipients For Injection Market

The Global Pharmaceutical Excipients for Injection market is witnessing a significant trend towards biofunctional excipient innovation. Developers are increasingly focusing on novel excipient chemistries and multifunctional materials that aid in enhancing the stability, solubility, and delivery of intricate injectable therapeutics. This trend emphasizes the importance of excipients that safeguard the integrity of biomolecules, enable controlled release mechanisms, and mitigate immunogenic responses. As a result, there is a surge in collaboration between excipient manufacturers and biologics developers, fostering formulation flexibility for next-generation modalities. Modular, application-specific excipient platforms are emerging, tailored to meet diverse therapeutic profiles and dynamic clinical demands, streamlining development processes significantly.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape
  • Value Chain Analysis
  • Pricing Analysis

Global Pharmaceutical Excipients for injection Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Solvents
  • Tonicity Agents
  • Buffer Agents
  • Surfactants
  • Preservatives
  • Antioxidants
  • Chelating Agents
  • Viscosity Enhancers
  • Colorants
  • Stabilizers
  • Others

Global Pharmaceutical Excipients for injection Market Size by Formulation Type & CAGR (2026-2033)

  • Market Overview
  • Water-Based Injection
  • Oil-Based Injection
  • Aqueous Solution
  • Non-Aqueous Solution

Global Pharmaceutical Excipients for injection Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Lyophilized Injections
  • Non-Lyophilized Injections
  • Emulsion Injections
  • Suspension Injections

Global Pharmaceutical Excipients for injection Market Size by End User Industry & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Laboratories
  • Hospitals & Clinics
  • Others

Global Pharmaceutical Excipients for injection Market Size & CAGR (2026-2033)

  • North America (Product Type, Formulation Type, Application, End User Industry)
    • US
    • Canada
  • Europe (Product Type, Formulation Type, Application, End User Industry)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Formulation Type, Application, End User Industry)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Formulation Type, Application, End User Industry)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Formulation Type, Application, End User Industry)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Ashland Global Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evonik Industries AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croda International Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • pharmaceutical excipients, inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DOW Chemical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharma Excipients
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JRS Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roquette Freres
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celanese Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gattefosse
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solvay SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ginkgo BioWorks
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wacker Chemie AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IMCD N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Signet Chemical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colorcon, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lubrizol Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle Health Science
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제